ATNM vs KLAC · rev $35.0M vs P/E 55, rev $13.58B
Actinium Pharmaceuticals Inc (ATNM) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US. It is led by Richard P. Wallace.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported KLAC revenue for 2026-06-30 was $13.58B. Net income was $4.83B. Revenue was up 11.7% from 2025-06-30 to 2026-06-30. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
ATNM currently screens at market cap $33.9M. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the ATNM and KLAC stock pages for the full models.
Not investment advice.